Pregnant primates have been shown to have a large diurnal (24 h r ) rhythm i n circulating melatonin (MEL). W e examined whether a l t e r a t i o n s i n circulating maternal MEL could be transferred to the f e t u s by giving i.v. injections or infusions of MEL to pregnant monkeys. Three rhesus monkeys with timed gestations (+ 1 d underwent hysterotomy a t 151 d gestation.
underwent hysterotomy a t 151 d gestation.
levels were determined by chloroform-extraction and authenticated by TLC i n the injection studies; MEL plasma levels were measured by RIA i n the infusion studies.
Three min a f t e r a maternal injection of a trace amount of
[ 3~]~~~ (lug, 150pCi) f e t a l plasma [ 3~]~~~ levels were 84 + 9%
(SE) of maternal [ 3~]~~~ levels (168 5 14 pgfml). P a r a l l e l r a t e of disappearance occurred i n both circulations over 30 min. Pea amniotic f l u i d [ 3~]~~~ levels of 17 + 2% maternal plasma levels occurred a t 30 min. Postmortem examination of CSF from 2 fetuse showed [ 3~]~~~ l e v e l s equal to f e t a l plasma l e v e l s . To mimic endogenous changes i n maternal MEL, 0.4 ugfmin aut h e n t i c MEL was infused to the mothers f o r 20 min. Prompt 6-to 12-fold MEL increments occurred i n both circulations; p a r a l l e l decrements occurred following the infusion.
These findings indicate the MEL, the putative pineal hormone, i s rapidly transferred to the fetus i n l a t e primate pregnancy. In previous studies,-we have sjlown t h a t administratian of h a increases the h a l f l i f e o f serum triodothyronine ( T 3 ) W e have now examined the e f f e c t of hGH on a loading dose of Tq i n 7 hypopituitary children (7 t o 18 years o f age). Before and aftex one month o f h a therapy (2 U t . i.w.) a s i n g l e dose o f T4 (1.2 mg/W) was administered o r a l l y , serum l e v e l s of T3 and T4 were measured a t 0,2,4,6,12,18,24 h r s . and daily t h e r e a f t e r f o r 6 days. Sennn levels of T4 peaked between 4 t o 6 h r s . post i ngestion and declined slowly t o baseline values by the 6th day. The values f o r s e m l e v e l s of T4 were not affected by h M therapy. There was a r i s e i n serum l e v e l s of T3 a s e a r l y a s 2 h r s . post ingestion but no uniform peak was discernable. The baseline values f o r s e m T3 were reached by t h e 6th day a f t e r several e r r a t i c fluctuations. Serum levels of T3 were s i g n if i c a n t l y higher a f t e r h a l therapy. This increase was more pronounced when the values were expressed a s the r a t i o of T3/T4. These d a t a indicate t h a t h a l causes an increase i n serum levels o f Tg. Although t h i s , in p a r t , may be due t o increase i n h a l f l i f e of serun T3, the long l a s t i n g elevation of serum T3, as obtained i n t h i s study, can only be explained by an increase in extrathyroidal conversion of T4 t o T3. A 7 month old child r a i s e d a s a femalehad ambi,quous g e n i t a l i a withclitoromegaly, posterior labial fusionanda urogenital sinus. Her peripheral karyotype was 46 XY. SherespondedtohCG stimulat i o n with an increase in serum testosterone from 59 t o 211 ng/dl despite elevated basal gonadotropins (LH 4 ng/ml, FSH 736ng/ml which had suggested gonadal f a i l u r e . A t age 15 months, her LH (46 ng/ml) and FSH (670 ng/ml) remained high and she underwent laparotomy which revealed a septate vagina, a hicornuate uterus and fallopian tubes (Miillerian structures) as well as b i l a t e r a l vasa deferentia (Wolffian s t r u c t u r e s ) . A right streak gonad contained multiple rGllerian ducts, whorls of collagen and hyperplastic steroid-secreting c e l l s hut no ova o r f o l l i c l e s . A l e f t intra-abdominal t e s t i s appeared normal by hoth l i g h t and electron microscopy with abundant perm c e l l s and appropriate Leydig and S e r t o l i c e l l u l t r a s t r u c t u r e f o r age. No evidence f o~ malignant change was seen.
The elevated FSH and persistent Miillerian structures in t h i s child had suggested deficient inhihin and antimiillerian hormone, respectively. The S e r t o l i c e l l i s the presumed source of these substances, however, no anatomic abnormality of the S e r t o l i cell could be demonstrated.
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Some children with c e n t r a l diabetes insipidus (DI) may I d e a s ADH under c e r t a i n conditions. W e have studied 10 patients with c e n t r a l D I ranging i n age from 3 to 18 years. Their evaluation included a dehydration t e s t and a t r i a l of c l o f i b r a t e therapy.
During the dehydration t e s t , hourly plasma and urine osmolali t i e s (Posm h Uosm) were measured. When there was a plateau i n Uosm, the patients received aq. P i t r e s s i n . Greater than a 9% r i s i n Uosm one hour l a t e r confirmed the diagnosis of D I . Four pat i e n t s had a Uosm higher than t h e i r Posm revealing releasable ADH. This occurred with marked t h i r s t associated with an elevate Posm. When the Posm exceeded 290 mOsm/l, the relationship of Uos to Posm was always subnormal i n our patients when compared to values obtained i n 127 normal subjects. By comparing simultaneou Uosm and Posm values, the diagnosis of D I can be strongly suspected; and, the diagnosis w i l l not be missed even i n p a t i e n t s with D I who can release ADH when moderately dehydrated.
The 10 p a t i e n t s received c l o f i b r a t e (500 mg q6h) f o r 3 to 7 days. Eight p a t i e n t s concentrated t h e i r urine 50 to 400% higher cian. E r r a t i c absorption of p i t r e s s i n i n o i l and the short action of aqueous p i t r e s s i n make these preparations unsuitable f o r t h e purpose. W e have used continuous infusion of aqueous p i t r e s s i n i n 2 p a t i e n t s (2 and 12 years of age) who developed DI imnediately following resection of craniopharpgioma. Both p a t i e n t s required prolonged parenteral therapy. An I.V. priming dose (0.05 U) of aqueous p i t r e s s i n was followed by continuous infusion of p i t r e s s i n a t the i n i t i a l dose of 3 uU/kg/min. Both p a t i e n t s were kept on maintenance I.V. f l u i d s and the r a t e of infused p i t r e s s i n was adjusted u n t i l the optimum dose of p i t r e s s i n was achieved. This was determined by monitoring serum and urinary sodium, urine v o l m and s p e c i f i c gravity and d a i l y weights. The o p t i r m dose of p i t r e s s i n appeared t o be 50 uU/kg/hr.
No untoward s i d e e f f e c t s were observed. The short half l i f e of I.V. aqueous p i t r e s s i n renders the minute t o minute adjustmnt of the dose a p r a c t i c a l f e a s i b i l i t y . 
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Complement studies were oerformeh on 21 patients, 2 months t c 16 years of age, with various types of thyroid disease. Circul a t i n g antithyroglobulin o r antimicrosomal antibodies were present in 12/21 ( t i t e r s > 1:40). All sera were quantitated for C4 (classical pathway); factor 6, properdin and properdin convertase ( a l t e r n a t i v e pathway); C3 and C3-C9 a c t i v i t y (both pathways). In addition, functional assays were done by determining the extent of complement activation by an immune complex (classical pathway) o r by zymosan, cobra venom f a c t o r , or rabbit erythrocytes (a1 ternative pathway). Abnormalities were found ir 16 patients, 11/12 with antithyroid antibodies and 519 without detectible antibodies. All but one of the abnormalitiesoccurre in the a l t e r n a t i v e pathway. These consisted primarily of low serum levels (> 3 SD below the mean f o r age) of factor B and properdin o r ineffective function with CoF. Such abnormalities suggest in vivo u t i l i z a t i o n of t h i s pathway. No association, however, e x i s t s between the t i t e r s of antibody and any abnormality. Since C3 i s deposited on the thyroid gland in many of these disorders, i t would appear t h a t i t i s the a l t e r n a t i v e pathway which i s responsible f o r t h a t deposition. Further, since antibody i s not usually associated with a l t e r n a t i v e pathway a c t i v i t y , i t s role in t h a t process i s open t o question. The management of DI i n a ~a t i e n t who reauires ~r o l o n e e d
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